The Schreiber Research Group focuses on promoting healthy communities through rigorous research, evaluation, and evidence-based consulting services aimed at addressing the opioid epidemic and substance use crisis. Their mission is to improve outcomes related to substances prone to misuse by informing communities, governments, and individuals about preventing substance use disorders and overdose deaths. TSRG collaborates with local, regional, and federal organizations to develop solutions for the opioid and benzodiazepine crises. Their commitment to research and community outreach helps to fill knowledge gaps and meet needs within communities.
